How Can We Increase The Adoption Of Bring-Your-Own-Device (BYOD) For Capturing Patient-Reported Outcomes (PROs) In Clinical Trials?

By Florence Mowlem, Director, eCOA at Medable

We are seeing a strong push to focus on incorporating the patient voice in drug development, after all, as Janet Woodcock, of the FDA has said, it is patients who are the true experts in their disease, and 

“It's clear you have to start with an understanding of the impact of the disease on the people who have it, and what they value most in terms of alleviation before you set up a measurement and go forward with truly patient-focused drug development.“¹                                                                                                                    

Most of us in the clinical trials industry know that we operate within a very conservative model, for good reason – but we also need to enable ‘controlled’ flexibility in our approaches where possible to foster patient centricity.